| PERIOD ENDING | 28-Feb-09 | 31-Jul-08 | 31-Jul-07 | | Total Revenue | 4,808 | 8,440 | 9,862 | | Cost of Revenue | 658 | 1,158 | 1,188 | | | Gross Profit | 4,150 | 7,281 | 8,674 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 117 | 207 | 212 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 4,033 | 7,075 | 8,462 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,985) | (5,308) | (2,145) | | Earnings Before Interest And Taxes | 4,033 | 7,075 | 7,143 | | Interest Expense |
-
| 161 | 191 | | Income Before Tax | 4,033 | 6,914 | 6,952 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (953) | 1,606 | 6,126 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (953) | 1,606 | 6,126 | | Preferred Stock And Other Adjustments | (912) | (1,962) | (1,931) | | | Net Income Applicable To Common Shares | ($1,865) | ($356) | $4,194 |
|
1.52% Nasdaq 
Income Statement
